Prognostic Value of Matrix Metalloproteinase 9 (MMP9) in Patients Following Off-Pump Coronary Artery Bypass Grafting

Background: Matrix metalloproteinase 9 (MMP9) has recently emerged as a risk predictor in patients with cardiovascular diseases (CVD). However, little is known regarding the significance of elevated plasma MMP9 levels in patients during the long-term period following myocardial revascularisation. We...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mikhail Popov, Siarhei Dabravolski, Vladislav Dontsov, Sergei Vzvarov, Evgeniy Agafonov, Dmitriy Zybin, Olga Radchenkova, Dmitriy Saveliev, Victoria Pronina, Natalia Kashirina, Liudmila Lipatova, Mikhail Peklo, Pavel Rutkevich, Elena Yanushevskaya, Alisa Sokolovskaya, Arkadiy Metelkin, Svetlana Verkhova, Nikita Nikiforov, Dmitriy Shumakov
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-06-01
coleção:	Life
Assuntos:	ischaemic heart disease matrix metalloproteinase 9 (MMP9) biomarker myocardial revascularisation
Acesso em linha:	https://www.mdpi.com/2075-1729/15/6/908
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!